Digital AI-powered drug discovery is outpacing regulators, with Eric... During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Digital AI and trusted data: The key to unlocking faster, more cost-... The artificial intelligence (AI) landscape is evolving at a rapid pace.
Digital Structuring the unstructured: Deterministic AI and white box... Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
R&D Sponsored Patentability and predictability in AI-assisted drug discove... Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.
Digital An investor’s perspective on bio and tech Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.
News Reaction to MSD's UK exit as government tries to renew talks The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap a £1bn investment spend.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
